Acelity Inc. announces global launch of Prevena Plus Incision Management System for wound closure.

Acelity Inc., a global wound care and regenerative medicine company, announced the expansion of its Prevena Therapy portfolio with the global launch of the Prevena Plus Incision Management System. The Prevena Plus System offers the proven effectiveness of closed incision negative pressure therapy (ciNPT) with improved versatility, portability, and flexibility. Prevena Therapy helps hold incision edges together and protects incisions from external infectious sources, and the new Prevena Plus System, now available in the United States and various global markets, includes a Customizable Dressing designed for linear, non-linear, and intersecting incisions up to 90cm in length.

The Prevena Plus Incision Management System is designed specifically for the management of surgical incisions that continue to drain following sutured or stapled closure. The System enables clinicians to manage incisions up to 90 cm in length with an adjustable dressing, and allows a surgeon to apply Prevana Therapy following a number of procedures including laparotomy, panniculectomy, spinal fusion, revision hip and knee arthroplasty and lower extremity trauma fracture. It uses a foam bolster to provide negative pressure at -125mmHg for up to seven days and patented SENSAT.R.A.C� Technology that monitors and maintains pressure at the incision site. It includes a replaceable 150ml canister to keep exudates away from the incision site.

Comment: 510(k) approval for Prevena Plus Incision System was given in February 2016. The Prevena Incision System was originally garnted 510(k) approval in 2010. The system has a CE mark accreditation.